logo

For the Inventor, By the Inventor

Vastra Frolunda, Sweden

Anita Lundblad

This inventor holds 6 USPTO granted patents. Top assignees: Astrazeneca Ab, Astra Aktiebolag. Active years: 2001-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita Lundblad. Retrieved from https://idiyas.com/inventor/anita-lundblad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Västra Frölunda, SE (2001 - 2002)
  • Västra Frolunda, SE (2005)
  • Molndal, SE (2007 - 2010)

Company Filing History:

goldMedal5 out of 1,534 
 
Astrazeneca Ab
 patents
silverMedal1 out of 271 
 
Astra Aktiebolag
 patents

Years Active: 2001-2010

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7763597 - Salts (2010-07-27),
2. 7273858 - Salts (2007-09-25),
3. 6888007 - Crystalline forms of EtO2C-Ch2-(R)Cgi-Aze-Pab-OH (2005-05-03),
4. 6479078 - Substantially crystalline form of melagatran (2002-11-12),
5. 6440939 - Crystalline forms (2002-08-27),
6. 6225287 - Crystalline forms (2001-05-01),

Title: Anita Lundblad: Innovator in Pharmaceutical Chemistry

Introduction

Anita Lundblad is a prominent inventor based in Vastra Frolunda, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as prodrugs for competitive inhibitors of trypsin-like proteases.

Latest Patents

Anita Lundblad holds a total of 6 patents. Her latest patents focus on pharmaceutically-acceptable acid addition salts of compounds that are useful in the treatment of conditions requiring the inhibition of thrombin, such as thrombosis. These compounds are characterized by specific alkyl substitutions and are designed to enhance the efficacy of anticoagulants.

Career Highlights

Throughout her career, Anita has worked with notable companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. Her work has been instrumental in advancing therapeutic options for patients requiring anticoagulation therapy.

Collaborations

Anita has collaborated with several professionals in her field, including Ursula Pettersson and Daniel Edvardsson. These collaborations have contributed to her innovative research and development efforts.

Conclusion

Anita Lundblad's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a key inventor in the industry. Her work continues to impact the development of important therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…